Curetis N.V. | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
10,721.00
12,434.00
13,840.00
15,172.30
19,498.00
23,745
Depreciation, Depletion & Amortization
1,272.00
1,448.00
1,708.00
1,744.00
1,317.00
1,256
Other Funds
2,376.00
3,310.00
23,624.00
365.20
1,822.00
43
Funds from Operations
7,073.00
7,676.00
8,076.00
13,063.10
16,436.00
22,525
Changes in Working Capital
2,099.00
195.00
392.00
2,610.00
765.00
566
Net Operating Cash Flow
9,172.00
7,481.00
8,468.00
15,673.10
15,671.00
21,959
Capital Expenditures
1,737.90
1,579.00
1,096.00
7,480.40
431.00
Sale of Fixed Assets & Businesses
0.90
38.00
-
-
-
Net Investing Cash Flow
1,737.00
1,537.00
1,096.00
7,480.40
431.00
Issuance/Reduction of Debt, Net
122.00
128.00
134.00
104.60
-
Net Financing Cash Flow
6,514.00
6,630.00
52,620.00
104.60
9,952.00
Net Change in Cash
4,395.00
2,388.00
43,066.00
23,228.30
6,521.00
Free Cash Flow
10,821.00
8,993.00
9,077.00
16,128.80
15,991.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
77.00
7
Other Sources
-
4.00
-
-
-
Change in Capital Stock
6,636.00
6,758.00
52,754.00
-
-
Exchange Rate Effect
-
-
10.00
29.80
371.00

About Curetis

View Profile
Address
Max-Eyth-Strasse 42
Holzgerlingen Baden Wuerttemberg 71088
Germany
Employees -
Website http://www.curetis.com
Updated 07/08/2019
Curetis NV engages in the manufacture, research and development, and commercialization of molecular microbiology solutions. It offers unyvero platform, which comprsises of the unyvero system with the A50 analyzer at its core, proprietary software, and single-use, application-specific cartridges. The company was founded by Johannes Bacher, Gerd Luedke and Andreas Boos on October 8, 2015 and is headquartered in Holzgerlingen, Germany.